Cargando…
Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113788/ https://www.ncbi.nlm.nih.gov/pubmed/35100613 http://dx.doi.org/10.1210/clinem/dgac055 |
_version_ | 1784709645537902592 |
---|---|
author | Viola, David Poma, Anello Marcello Elisei, Rossella Basolo, Fulvio |
author_facet | Viola, David Poma, Anello Marcello Elisei, Rossella Basolo, Fulvio |
author_sort | Viola, David |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9113788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-91137882022-05-18 Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management” Viola, David Poma, Anello Marcello Elisei, Rossella Basolo, Fulvio J Clin Endocrinol Metab Online Only Articles Oxford University Press 2022-02-01 /pmc/articles/PMC9113788/ /pubmed/35100613 http://dx.doi.org/10.1210/clinem/dgac055 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Endocrine Society. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Online Only Articles Viola, David Poma, Anello Marcello Elisei, Rossella Basolo, Fulvio Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management” |
title | Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management” |
title_full | Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management” |
title_fullStr | Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management” |
title_full_unstemmed | Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management” |
title_short | Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management” |
title_sort | response to letter to the editor from green and gosmanov: “tall cell percentage alone in ptc without aggressive features should not guide patients’ clinical management” |
topic | Online Only Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113788/ https://www.ncbi.nlm.nih.gov/pubmed/35100613 http://dx.doi.org/10.1210/clinem/dgac055 |
work_keys_str_mv | AT violadavid responsetolettertotheeditorfromgreenandgosmanovtallcellpercentagealoneinptcwithoutaggressivefeaturesshouldnotguidepatientsclinicalmanagement AT pomaanellomarcello responsetolettertotheeditorfromgreenandgosmanovtallcellpercentagealoneinptcwithoutaggressivefeaturesshouldnotguidepatientsclinicalmanagement AT eliseirossella responsetolettertotheeditorfromgreenandgosmanovtallcellpercentagealoneinptcwithoutaggressivefeaturesshouldnotguidepatientsclinicalmanagement AT basolofulvio responsetolettertotheeditorfromgreenandgosmanovtallcellpercentagealoneinptcwithoutaggressivefeaturesshouldnotguidepatientsclinicalmanagement |